3 Stocks RBC Says Are Ready to Rip Higher, , on November 6, 2020 at 3:53 pm

Financial News
By
On November 6, 2020
In Financial News
Tags:

Some investment firms stand higher than the others, judging by results. The premier Canadian bank RBC is one of these, rated in the top five of Wall Street’s stock research firms.Recently, RBC’s analysts have turned their gaze on a variety of companies, large and small, from the chemical industry to retail staples, and they are finding opportunities for investors. The stocks that have caught RBC’s attention show considerable upside for the coming year. We’ve ran them through TipRanks database to see what other Wall Street’s analysts have to say about them.Axalta Coating Systems (AXTA)First on our list of RBC picks is Axalta Coating, a company in the automotive coatings industry. Modern coatings are a high-tech treatment, more than just paints and wax finishes, they provide sealant and weather-proofing protection for vehicle surfaces. The company also produces coatings for industrial applications, and boasts 10 different brands in its product line.Axalta saw both hard times and a strong rebound in 2020. Earnings slipped in Q1, and turned negative in Q2 – but the recent Q3 report showed 59 cents per share profit. This was a major increase from the previous quarter’s 15-cent net loss – and was 13% higher than the year-ago quarter. Revenues, at $1.03 billion, were the highest since 4Q19.RBC’s Arun Viswanathan, a 5-star analyst, writes of this company, “AXTA’s recovery is under way and we believe conditions will continue to slowly improve, which should benefit profitability as volumes return and restructuring programs are implemented… We believe AXTA’s cost-reduction programs, and the gradual return of volumes should benefit AXTA for several quarters. We also believe AXTA can generate sufficient FCF to deliver its balance sheet and maintain healthy financial flexibility.”In line with these comments, Viswanathan rates the stock as Outperform (i.e. Buy). His price target of $34 suggests the stock has room for 28% growth to the upside in the next year. (To watch Viswanathan’s track record, click here)Axalta has a Strong Buy analyst consensus rating, based on 9 recent reviews breaking down to 7 Buys and 2 Holds. The stock is priced at $26.67, and its $31.89 average price target implies a 19.5% one-year upside. (See AXTA stock analysis on TipRanks)Rayonier Advanced Materials (RYAM)Next up is a small-cap player in the chemical industry. Rayonier specializes in cellulose-based fiber products for the cosmetic, food, paint, and pharmaceutical industries. The company’s products are used in paper and other packaging, and it operates manufacturing facilities in US, Canada, and France. Rayonier’s stock performance has shown a clear recovering from the difficulties of early 2020. The shares started falling before the big market crash in February/March, but has since rebounded and regained its lost value. RYAM is currently up 14% year-to-date.Earnings have shown sequential improvement from -39 cents in the first quarter to -20 cents in the second, while turning the corner in Q3 with 45 cents gain. The company has beaten the estimates in the last three quarters.Looking at this stock for RBC, 5-star analyst Paul Quinn sees a clear path forward for Rayonier, saying, “Rayonier Advanced reported Q3 results that were above RBC/consensus expectations due to much better-than-expected High Purity Cellulose segment results, with Cellulose Specialties in particular exceeding our estimates. In our view, negative trends in the company’s core Cellulose Specialties business have weighed on the share price over the last few years; while just one data point, positive trends and (slowly) falling leverage make Rayonier Advanced an attractive investment, in our view.” To this end, Quinn rates RYAM shares an Outperform (i.e. Buy) along with a $5.5 price target. This figure implies a 26% upside from current levels. (To watch Quinn’s track record, click here)The Gap, Inc. (GPS)Last up is The Gap, a familiar name in retail. The company is a staple of the shopping mall scene, and the decline in brick-and-mortar retail during 1H20 hit hard. The Gap’s earnings remained stable in Q1, but fell drastically in Q2, to a $2.51 net loss. In Q3, the results were better, with the EPS loss mitigating to a mere 5 cents. Revenues rose sequentially from $2.1 billion to $3.3 billion.The share performance has been good for investors since late March. The stock has rebounded from the mid-winter losses, regaining all of its losses, and is now trading with a year-to-date gain of 30%.The Gap has managed this turnaround while also shoring up liquidity and plotting a course forward. The company paid off half a billion dollars in outstanding debt during the spring, and raised $2.25 billion in capital through a secured note issue. A new revolving credit facility, for $1.87 billion, completed the company’s liquidity moves.RBC’s retail expert Kate Fitzsimons is upbeat on Gap’s ability to chart its course forward. She rates the stock Outperform (i.e. Buy), and sets a $28 price target implying a 28% upside for the year ahead. (To watch Fitzsimons’s track record, click here)Supporting her stance, Fitzsimons writes, “We [are] incrementally positive on Gap Inc.’s ability to emerge from the COVID crisis a more profitable company with expense actions at Gap and Banana Republic shoring up profitability at those brands, and with viable growth and margin trajectories at Old Navy and Athleta… With persisting questions about the fundamental health of the mall post-COVID-19, we note that Gap’s store footprint is undergoing significantly accelerated rightsizing, and the current crisis presents an opportunity for the team to reoptimize its cost structure through a combination of store closures, rent reductions, and headcount rightsizing at HQ.”Overall, GPS holds a Moderate Buy rating from the analyst consensus. The stock has received 16 recent reviews, including 4 Buys and 12 Holds. The average share price is $21.31, suggesting a 3% downside from the current share price of $21.94. (See GPS stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.,

3 Stocks RBC Says Are Ready to Rip HigherSome investment firms stand higher than the others, judging by results. The premier Canadian bank RBC is one of these, rated in the top five of Wall Street’s stock research firms.Recently, RBC’s analysts have turned their gaze on a variety of companies, large and small, from the chemical industry to retail staples, and they are finding opportunities for investors. The stocks that have caught RBC’s attention show considerable upside for the coming year. We’ve ran them through TipRanks database to see what other Wall Street’s analysts have to say about them.Axalta Coating Systems (AXTA)First on our list of RBC picks is Axalta Coating, a company in the automotive coatings industry. Modern coatings are a high-tech treatment, more than just paints and wax finishes, they provide sealant and weather-proofing protection for vehicle surfaces. The company also produces coatings for industrial applications, and boasts 10 different brands in its product line.Axalta saw both hard times and a strong rebound in 2020. Earnings slipped in Q1, and turned negative in Q2 – but the recent Q3 report showed 59 cents per share profit. This was a major increase from the previous quarter’s 15-cent net loss – and was 13% higher than the year-ago quarter. Revenues, at $1.03 billion, were the highest since 4Q19.RBC’s Arun Viswanathan, a 5-star analyst, writes of this company, “AXTA’s recovery is under way and we believe conditions will continue to slowly improve, which should benefit profitability as volumes return and restructuring programs are implemented… We believe AXTA’s cost-reduction programs, and the gradual return of volumes should benefit AXTA for several quarters. We also believe AXTA can generate sufficient FCF to deliver its balance sheet and maintain healthy financial flexibility.”In line with these comments, Viswanathan rates the stock as Outperform (i.e. Buy). His price target of $34 suggests the stock has room for 28% growth to the upside in the next year. (To watch Viswanathan’s track record, click here)Axalta has a Strong Buy analyst consensus rating, based on 9 recent reviews breaking down to 7 Buys and 2 Holds. The stock is priced at $26.67, and its $31.89 average price target implies a 19.5% one-year upside. (See AXTA stock analysis on TipRanks)Rayonier Advanced Materials (RYAM)Next up is a small-cap player in the chemical industry. Rayonier specializes in cellulose-based fiber products for the cosmetic, food, paint, and pharmaceutical industries. The company’s products are used in paper and other packaging, and it operates manufacturing facilities in US, Canada, and France. Rayonier’s stock performance has shown a clear recovering from the difficulties of early 2020. The shares started falling before the big market crash in February/March, but has since rebounded and regained its lost value. RYAM is currently up 14% year-to-date.Earnings have shown sequential improvement from -39 cents in the first quarter to -20 cents in the second, while turning the corner in Q3 with 45 cents gain. The company has beaten the estimates in the last three quarters.Looking at this stock for RBC, 5-star analyst Paul Quinn sees a clear path forward for Rayonier, saying, “Rayonier Advanced reported Q3 results that were above RBC/consensus expectations due to much better-than-expected High Purity Cellulose segment results, with Cellulose Specialties in particular exceeding our estimates. In our view, negative trends in the company’s core Cellulose Specialties business have weighed on the share price over the last few years; while just one data point, positive trends and (slowly) falling leverage make Rayonier Advanced an attractive investment, in our view.” To this end, Quinn rates RYAM shares an Outperform (i.e. Buy) along with a $5.5 price target. This figure implies a 26% upside from current levels. (To watch Quinn’s track record, click here)The Gap, Inc. (GPS)Last up is The Gap, a familiar name in retail. The company is a staple of the shopping mall scene, and the decline in brick-and-mortar retail during 1H20 hit hard. The Gap’s earnings remained stable in Q1, but fell drastically in Q2, to a $2.51 net loss. In Q3, the results were better, with the EPS loss mitigating to a mere 5 cents. Revenues rose sequentially from $2.1 billion to $3.3 billion.The share performance has been good for investors since late March. The stock has rebounded from the mid-winter losses, regaining all of its losses, and is now trading with a year-to-date gain of 30%.The Gap has managed this turnaround while also shoring up liquidity and plotting a course forward. The company paid off half a billion dollars in outstanding debt during the spring, and raised $2.25 billion in capital through a secured note issue. A new revolving credit facility, for $1.87 billion, completed the company’s liquidity moves.RBC’s retail expert Kate Fitzsimons is upbeat on Gap’s ability to chart its course forward. She rates the stock Outperform (i.e. Buy), and sets a $28 price target implying a 28% upside for the year ahead. (To watch Fitzsimons’s track record, click here)Supporting her stance, Fitzsimons writes, “We [are] incrementally positive on Gap Inc.’s ability to emerge from the COVID crisis a more profitable company with expense actions at Gap and Banana Republic shoring up profitability at those brands, and with viable growth and margin trajectories at Old Navy and Athleta… With persisting questions about the fundamental health of the mall post-COVID-19, we note that Gap’s store footprint is undergoing significantly accelerated rightsizing, and the current crisis presents an opportunity for the team to reoptimize its cost structure through a combination of store closures, rent reductions, and headcount rightsizing at HQ.”Overall, GPS holds a Moderate Buy rating from the analyst consensus. The stock has received 16 recent reviews, including 4 Buys and 12 Holds. The average share price is $21.31, suggesting a 3% downside from the current share price of $21.94. (See GPS stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage